The Rock & Roll Shrink Radio Show: Ep. 133 Jagged Little Pill – CDK5 Inhibitors

NDB Media

English - July 07, 2022 03:00 - 1 hour - 29.2 MB - ★★★★ - 4 ratings
Society & Culture travel star trek star wars yankees harry potter finance sports current events Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Rock & Roll Shrink Ep. 132 - Out of the Blue - Blue Zones, Health, & Longevity

Next Episode: Rock and Roll Shrink / Episode Re-Play

An article was just recently published out on social media a couple of weeks ago (June), that talks about a class of drugs called CDK5 Inhibitors.

What laypeople may want to know about this study, and this problem in general, is the role of CDK5 (Cyclin-dependent kinase 5) in multiple health problems, and how this latest development might lead to new methods that may bring relief to people. The details are a bit hard-science crunchy, but in summary it is a protein (an enzyme) that affects not only a lot of brain functions, but also some physiological functions as well, including Alzheimer’s, MS, and fighting Cancer.

Tonight, we will discuss:
What is CDK5, and its role in multiple health conditionsPossibilities for CDK5 Inhibitors in Future MedicineCounterpoints and CritiquesConclusions, Closing Remarks, & Final Suggestions
We'll start off the evening with some topic-relevant Classic Rock played by Dr. Mathis, followed by Classic Rock trivia in "The Rock & Roll Shrink Recalls," followed by our topic discussion.